Literature DB >> 2064112

Individualized therapy versus standard regimens in the treatment of Mycobacterium avium infections.

L B Heifets, M D Iseman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064112     DOI: 10.1164/ajrccm/144.1.1

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  9 in total

Review 1.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 2.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice.

Authors:  L Fattorini; Y Xiao; M Mattei; Y Li; E Iona; M L Ricci; O F Thoresen; R Creti; G Orefici
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

Review 4.  Structural biological study of self-resistance determinants in antibiotic-producing actinomycetes.

Authors:  Masanori Sugiyama
Journal:  J Antibiot (Tokyo)       Date:  2015-04-15       Impact factor: 2.649

5.  Mycobacteria in stool specimens: the nonvalue of smears for predicting culture results.

Authors:  A Morris; L B Reller; M Salfinger; K Jackson; A Sievers; B Dwyer
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

6.  Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis.

Authors:  N E Cáceres; N B Harris; J F Wellehan; Z Feng; V Kapur; R G Barletta
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

7.  Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.

Authors:  Irma A J M Bakker-Woudenberg; Wim van Vianen; Dick van Soolingen; Henri A Verbrugh; Michiel A van Agtmael
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

8.  Crystallographic study to determine the substrate specificity of an L-serine-acetylating enzyme found in the D-cycloserine biosynthetic pathway.

Authors:  Kosuke Oda; Yasuyuki Matoba; Takanori Kumagai; Masafumi Noda; Masanori Sugiyama
Journal:  J Bacteriol       Date:  2013-02-08       Impact factor: 3.490

Review 9.  Nontuberculous mycobacterial pulmonary infections.

Authors:  Margaret M Johnson; John A Odell
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.